News & Events :: Can-Fite BioPharma Ltd. (CANF)

Recent News View All News

May 13, 2026 7:00am EDT

Following Positive Phase 2a Pancreatic Cancer Data, Can-Fite Advances Namodenoson into Phase 2b Combination Study with Immunotherapy

Apr 30, 2026 8:31am EDT

Can-Fite Reports Positive Phase 2a Data with Namodenoson in Pancreatic Cancer; 35% of Patients Remain on Therapy, Including One Beyond 16 Months

Upcoming Events View IR Calendar

May 28, 2026 3:00 pm IDT

2026 Annual General Meeting of Shareholders

View IR Calendar

Email Alerts

Sign up for email alerts for Press Releases & SEC Filings